Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 9/2018

04.06.2018 | Review Article

Outcomes of Surgical and Endoscopic Resection of Duodenal Neuroendocrine Tumours (NETs): a Systematic Review of the Literature

verfasst von: Bobby V. M. Dasari, Sarah Al-Shakhshir, Timothy M. Pawlik, Tahir Shah, Ravi Marudanayagam, Robert P. Sutcliffe, Darius F. Mirza, Paolo Muiesan, Keith J. Roberts, John Isaac

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 9/2018

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Duodenal neuroendocrine tumours (dNETs) comprise about 2% of all the NETs. Treatment of dNETs involves resection of the tumour either by endoscopic or surgical resection. Surgical or endoscopic local resection of the lesion is usually a more conservative and less morbid option compared with a more radical pancreaticoduodenectomy. However, inadequate clearance by local resection might result in recurrent disease with reduced overall survival.

Methods

The current systematic review compared the differences in outcomes of endoscopic resection (ER), local resection (LR) and pancreaticoduodenectomy (PD) in the management of dNETs. Searches were performed on MEDLINE, PubMed, Embase and Cochrane databases using MeSH keyword combinations: ‘duodenal’, AND, ‘neuroendocrine tumours’. All relevant articles published up to 2016 were included. Post-operative morbidity, R0 resection status and recurrence rates were the outcomes assessed.

Results

Eight non-randomised retrospective studies with 335 participants were included (LR = 122; PD = 118; ER = 64). While PD was associated with higher morbidity compared with LR (27/64 vs. 10/74; P = 0.002), PD was associated with a higher incidence of an R0 resection (3/97 vs. 15/97; P = 0.007) as well as lower recurrence rates (3/51 vs. 6/46; P = 0.21). ER was associated with a higher positive resection margin status versus LR (22/51 vs. 14/91; P = 0.0002). Recurrence at follow-up was not different among patients with dNETs who underwent PD versus LR.

Conclusions

Radical surgical resection in the form of PD was associated with higher post-operative morbidity among patients with dNETs yet provided better margin clearance. Patients with dNETs need systematic evaluation with a view to obtain most of the information about the prognostic factors in order to tailor the treatment options.
Literatur
1.
Zurück zum Zitat Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, et al. One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States. J Clin Oncol. 2008 Jun 20;26(18):3063–72.CrossRefPubMed Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, et al. One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States. J Clin Oncol. 2008 Jun 20;26(18):3063–72.CrossRefPubMed
2.
Zurück zum Zitat Shroff SR, Kushnir VM, Wani SB, Gupta N, Jonnalagadda SS, Murad F, et al. Efficacy of Endoscopic Mucosal Resection for Management of Small Duodenal Neuroendocrine Tumors. Surg Laparosc Endosc Percutan Tech. 2015 Oct;25(5):e134–9.CrossRefPubMed Shroff SR, Kushnir VM, Wani SB, Gupta N, Jonnalagadda SS, Murad F, et al. Efficacy of Endoscopic Mucosal Resection for Management of Small Duodenal Neuroendocrine Tumors. Surg Laparosc Endosc Percutan Tech. 2015 Oct;25(5):e134–9.CrossRefPubMed
3.
Zurück zum Zitat Min B-H, Kim ER, Lee JH, Kim K-M, Min YW, Rhee P-L, et al. Management Strategy for Small Duodenal Carcinoid Tumors: Does Conservative Management with Close Follow-Up Represent an Alternative to Endoscopic Treatment. Digestion. 2013;87(4): 247–53.CrossRefPubMed Min B-H, Kim ER, Lee JH, Kim K-M, Min YW, Rhee P-L, et al. Management Strategy for Small Duodenal Carcinoid Tumors: Does Conservative Management with Close Follow-Up Represent an Alternative to Endoscopic Treatment. Digestion. 2013;87(4): 247–53.CrossRefPubMed
4.
Zurück zum Zitat Delle Fave G, Kwekkeboom DJ, Van Cutsem E, Rindi G, Kos-Kudla B, Knigge U, et al. ENETS Consensus Guidelines for the Management of Patients with Gastroduodenal Neoplasms. Neuroendocrinology. 2012;95(2):74–87.CrossRefPubMed Delle Fave G, Kwekkeboom DJ, Van Cutsem E, Rindi G, Kos-Kudla B, Knigge U, et al. ENETS Consensus Guidelines for the Management of Patients with Gastroduodenal Neoplasms. Neuroendocrinology. 2012;95(2):74–87.CrossRefPubMed
5.
Zurück zum Zitat Min BH, Kim ER, Lee JH, Kim KM, Min YW, Rhee PL, et al. Management strategy for small duodenal carcinoid tumors: Does conservative management with close follow-up represent an alternative to endoscopic treatment? Digestion. 2013;87(4):247–53.CrossRefPubMed Min BH, Kim ER, Lee JH, Kim KM, Min YW, Rhee PL, et al. Management strategy for small duodenal carcinoid tumors: Does conservative management with close follow-up represent an alternative to endoscopic treatment? Digestion. 2013;87(4):247–53.CrossRefPubMed
6.
Zurück zum Zitat Witzigmann H, Loracher C, Geissler F, Wagner T, Tannapfel A, Uhlmann D, et al. Neuroendocrine tumours of the duodenum: Clinical aspects, pathomorphology and therapy. Langenbeck’s Arch Surg. 2002;386(7):525–33.CrossRef Witzigmann H, Loracher C, Geissler F, Wagner T, Tannapfel A, Uhlmann D, et al. Neuroendocrine tumours of the duodenum: Clinical aspects, pathomorphology and therapy. Langenbeck’s Arch Surg. 2002;386(7):525–33.CrossRef
7.
Zurück zum Zitat Ricci JL. Carcinoid of the ampulla of Vater. Local resection or pancreaticoduodenectomy. Cancer. 1993 Feb 1;71(3):686–90.CrossRefPubMed Ricci JL. Carcinoid of the ampulla of Vater. Local resection or pancreaticoduodenectomy. Cancer. 1993 Feb 1;71(3):686–90.CrossRefPubMed
8.
Zurück zum Zitat Hoffmann KM, Furukawa M, Jensen RT. Duodenal neuroendocrine tumors: Classification, functional syndromes, diagnosis and medical treatment. Best Pract Res Clin Gastroenterol. 2005 Oct;19(5):675–97.CrossRefPubMed Hoffmann KM, Furukawa M, Jensen RT. Duodenal neuroendocrine tumors: Classification, functional syndromes, diagnosis and medical treatment. Best Pract Res Clin Gastroenterol. 2005 Oct;19(5):675–97.CrossRefPubMed
9.
Zurück zum Zitat Soga J. Early-stage carcinoids of the gastrointestinal tract: an analysis of 1914 reported cases. Cancer. 2005 Apr 15;103(8):1587–95.CrossRefPubMed Soga J. Early-stage carcinoids of the gastrointestinal tract: an analysis of 1914 reported cases. Cancer. 2005 Apr 15;103(8):1587–95.CrossRefPubMed
10.
Zurück zum Zitat Zyromski NJ, Kendrick ML, Nagorney DM, Grant CS, Donohue JH, Farnell MB, et al. Duodenal carcinoid tumors: how aggressive should we be? J Gastrointest Surg. 5(6):588–93. Zyromski NJ, Kendrick ML, Nagorney DM, Grant CS, Donohue JH, Farnell MB, et al. Duodenal carcinoid tumors: how aggressive should we be? J Gastrointest Surg. 5(6):588–93.
11.
Zurück zum Zitat Hartel M, Wente MN, Sido B, Friess H, Büchler MW. Carcinoid of the ampulla of Vater. J Gastroenterol Hepatol. 2005 May;20(5):676–81.CrossRefPubMed Hartel M, Wente MN, Sido B, Friess H, Büchler MW. Carcinoid of the ampulla of Vater. J Gastroenterol Hepatol. 2005 May;20(5):676–81.CrossRefPubMed
12.
Zurück zum Zitat Randle RW, Ahmed S, Newman NA, Clark CJ. Clinical outcomes for neuroendocrine tumors of the duodenum and ampulla of Vater: a population-based study. J Gastrointest Surg. 2014 Feb 10;18(2):354–62.CrossRefPubMed Randle RW, Ahmed S, Newman NA, Clark CJ. Clinical outcomes for neuroendocrine tumors of the duodenum and ampulla of Vater: a population-based study. J Gastrointest Surg. 2014 Feb 10;18(2):354–62.CrossRefPubMed
13.
Zurück zum Zitat Margonis GA, Samaha M, Kim Y, Postlewait LML, Kunz P, Maithel S, et al. A Multi-institutional Analysis of Duodenal Neuroendocrine Tumors: Tumor Biology Rather than Extent of Resection Dictates Prognosis. J Gastrointest Surg. 2016;20(6):1098–105.CrossRefPubMed Margonis GA, Samaha M, Kim Y, Postlewait LML, Kunz P, Maithel S, et al. A Multi-institutional Analysis of Duodenal Neuroendocrine Tumors: Tumor Biology Rather than Extent of Resection Dictates Prognosis. J Gastrointest Surg. 2016;20(6):1098–105.CrossRefPubMed
14.
Zurück zum Zitat Higgins JP, Green S. Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series. Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series. 2008. 1–649 p. Higgins JP, Green S. Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series. Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series. 2008. 1–649 p.
15.
Zurück zum Zitat Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. Vol. 4, The Cochrane Collaboration. 2011. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. Vol. 4, The Cochrane Collaboration. 2011.
16.
Zurück zum Zitat Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998 Dec 30;17(24):2815–34.CrossRefPubMed Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998 Dec 30;17(24):2815–34.CrossRefPubMed
17.
Zurück zum Zitat Ishido K, Tanabe S, Higuchi K, Sasaki T, Katada C, Azuma M, et al. Clinicopathological evaluation of duodenal well-differentiated endocrine tumors. World J Gastroenterol. 2010;16(36):4583–8.CrossRefPubMedPubMedCentral Ishido K, Tanabe S, Higuchi K, Sasaki T, Katada C, Azuma M, et al. Clinicopathological evaluation of duodenal well-differentiated endocrine tumors. World J Gastroenterol. 2010;16(36):4583–8.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Weatherall T, Denbo J, Sharpe J, Martin M, O’Brien T, Gupta R, et al. Well-Differentiated, Non-Functional, Non-Ampullary Duodenal Neuroendocrine Tumors: Toward Defining Evaluation and Management. World J Surg. 2017;41(3):844–50.CrossRefPubMed Weatherall T, Denbo J, Sharpe J, Martin M, O’Brien T, Gupta R, et al. Well-Differentiated, Non-Functional, Non-Ampullary Duodenal Neuroendocrine Tumors: Toward Defining Evaluation and Management. World J Surg. 2017;41(3):844–50.CrossRefPubMed
19.
Zurück zum Zitat Gincul R, Ponchon T, Napoleon B, Scoazec J-Y, Guillaud O, Saurin J-C, et al. Endoscopic treatment of sporadic small duodenal and ampullary neuroendocrine tumors. Endoscopy. 2016 Aug 5;48(11):979–86.CrossRefPubMed Gincul R, Ponchon T, Napoleon B, Scoazec J-Y, Guillaud O, Saurin J-C, et al. Endoscopic treatment of sporadic small duodenal and ampullary neuroendocrine tumors. Endoscopy. 2016 Aug 5;48(11):979–86.CrossRefPubMed
20.
Zurück zum Zitat Iwasaki T, Nara S, Kishi Y, Esaki M, Shimada K, Hiraoka N. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature. Langenbeck’s Arch Surg. Langenbeck’s Archives of Surgery; 2017;402(6):925–33.CrossRef Iwasaki T, Nara S, Kishi Y, Esaki M, Shimada K, Hiraoka N. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature. Langenbeck’s Arch Surg. Langenbeck’s Archives of Surgery; 2017;402(6):925–33.CrossRef
21.
Zurück zum Zitat Untch BR, Bonner KP, Roggin KK, Reidy-Lagunes D, Klimstra DS, Schattner MA, et al. Pathologic Grade and Tumor Size are Associated with Recurrence-Free Survival in Patients with Duodenal Neuroendocrine Tumors. J Gastrointest Surg. 2014;18(3):457–63.CrossRefPubMed Untch BR, Bonner KP, Roggin KK, Reidy-Lagunes D, Klimstra DS, Schattner MA, et al. Pathologic Grade and Tumor Size are Associated with Recurrence-Free Survival in Patients with Duodenal Neuroendocrine Tumors. J Gastrointest Surg. 2014;18(3):457–63.CrossRefPubMed
22.
Zurück zum Zitat Baptiste GG, Postlewait LM, Ethun CG, Le N, Russell MC, Kooby DA, et al. Is there an Optimal Surgical Approach to Neuroendocrine Tumors of the Ampulla? A Single Institution Experience Over 15 Years. Am Surg. 2016 Jul;82(7):637–43.PubMed Baptiste GG, Postlewait LM, Ethun CG, Le N, Russell MC, Kooby DA, et al. Is there an Optimal Surgical Approach to Neuroendocrine Tumors of the Ampulla? A Single Institution Experience Over 15 Years. Am Surg. 2016 Jul;82(7):637–43.PubMed
23.
Zurück zum Zitat Burke CA, Beck GJ, Church JM, van Stolk RU. The natural history of untreated duodenal and ampullary adenomas in patients with familial adenomatous polyposis followed in an endoscopic surveillance program. Gastrointest Endosc. 1999 Mar;49(3 Pt 1):358–64.CrossRefPubMed Burke CA, Beck GJ, Church JM, van Stolk RU. The natural history of untreated duodenal and ampullary adenomas in patients with familial adenomatous polyposis followed in an endoscopic surveillance program. Gastrointest Endosc. 1999 Mar;49(3 Pt 1):358–64.CrossRefPubMed
24.
Zurück zum Zitat Makhlouf HR, Burke AP, Sobin LH. Carcinoid tumors of the ampulla of Vater: a comparison with duodenal carcinoid tumors. Cancer. 1999 Mar 15;85(6):1241–9.CrossRefPubMed Makhlouf HR, Burke AP, Sobin LH. Carcinoid tumors of the ampulla of Vater: a comparison with duodenal carcinoid tumors. Cancer. 1999 Mar 15;85(6):1241–9.CrossRefPubMed
25.
Zurück zum Zitat Bornstein-Quevedo L, Gamboa-Domínguez A. Carcinoid tumors of the duodenum and ampulla of vater: a clinicomorphologic, immunohistochemical, and cell kinetic comparison. Hum Pathol. 2001 Nov;32(11):1252–6.CrossRefPubMed Bornstein-Quevedo L, Gamboa-Domínguez A. Carcinoid tumors of the duodenum and ampulla of vater: a clinicomorphologic, immunohistochemical, and cell kinetic comparison. Hum Pathol. 2001 Nov;32(11):1252–6.CrossRefPubMed
27.
Zurück zum Zitat Huang JJ, Yeo CJ, Sohn TA, Lillemoe KD, Sauter PK, Coleman J, et al. Quality of life and outcomes after pancreaticoduodenectomy. Ann Surg. 2000 Jun;231(6):890–8.CrossRefPubMedPubMedCentral Huang JJ, Yeo CJ, Sohn TA, Lillemoe KD, Sauter PK, Coleman J, et al. Quality of life and outcomes after pancreaticoduodenectomy. Ann Surg. 2000 Jun;231(6):890–8.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Chen G, Liu S, Zhao Y, Dai M, Zhang T. Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration for pancreatic cancer: A meta-analysis. Pancreatology. 2013 May;13(3):298–304.CrossRefPubMed Chen G, Liu S, Zhao Y, Dai M, Zhang T. Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration for pancreatic cancer: A meta-analysis. Pancreatology. 2013 May;13(3):298–304.CrossRefPubMed
Metadaten
Titel
Outcomes of Surgical and Endoscopic Resection of Duodenal Neuroendocrine Tumours (NETs): a Systematic Review of the Literature
verfasst von
Bobby V. M. Dasari
Sarah Al-Shakhshir
Timothy M. Pawlik
Tahir Shah
Ravi Marudanayagam
Robert P. Sutcliffe
Darius F. Mirza
Paolo Muiesan
Keith J. Roberts
John Isaac
Publikationsdatum
04.06.2018
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 9/2018
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-018-3825-7

Weitere Artikel der Ausgabe 9/2018

Journal of Gastrointestinal Surgery 9/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.